Table 5a.
Effect of post-CCl4 oral treatments with 125–500 mg/kg/day of MIASE on serum ALT, AST, ALP, TB and CB in the CCl4-treated rats.
| Groups | ALT (IU/L) | AST (IU/L) | ALP (IU/L) | TB (mg/dl) | CB (mg/dl) |
|---|---|---|---|---|---|
| I | 15.50 ± 0.76 | 36.00 ± 2.24 | 27.70 ± 1.81 | 1.29 ± 0.07 | 0.24 ± 0.00 |
| II | 54.83 ± 2.65c | 97.83 ± 2.69c | 69.13 ± 3.81c | 1.98 ± 0.04c | 1.39 ± 0.06c |
| III | 15.00 ± 1.37f | 21.17 ± 2.20e | 41.73 ± 1.86f | 1.18 ± 0.11f | 0.30 ± 0.01f |
| IV | 23.17 ± 1.28e | 64.33 ± 1.61e | 51.37 ± 4.54e | 1.58 ± 0.10e | 0.30 ± 0.01f |
| V | 15.50 ± 0.76f | 50.67 ± 4.49f | 41.70 ± 3.17f | 1.16 ± 0.12f | 0.28 ± 0.02f |
| VI | 12.67 ± 0.71f | 42.67 ± 2.62f | 32.72 ± 2.10f | 1.21 ± 0.07f | 0.29 ± 0.02f |
c represents a significant increase at p < 0.0001 when compared to Group I values while e and f represent significant decreases at p < 0.001 and p < 0.0001, respectively, when compared to Group II values.